Association between specific KRAS mutations and the clinicopathological characteristics of colorectal tumors
Authors:
- 27 October 2014
- journal article
- Published by Spandidos Publications in Molecular and Clinical Oncology
- Vol. 3 (1) , 179-184
Abstract
The aim of this study was to investigate the clinicopathological characteristics and distribution by tumor localization of KRAS point mutations in metastatic colorectal cancer. A total of 189 patients diagnosed with colorectal cancer between 2007 and 2014, who were either metastatic at the time of diagnosis or developed metastasis subsequently, were included in this study. KRAS mutation analysis was performed in the primary tumor tissues and KRAS mutations were identified in 47.6% of the patients. There was a high frequency of the p.G13D point mutation in left‑colon tumors (p=0.011), while the p.G12D point mutation was more frequent in right‑colon tumors (p=0.004). KRAS wild‑type frequency (p=0.02) was higher among patients aged 50‑year‑old group (p=0.03) and codon 13 mutations were more common in the <70‑year‑old group (p=0.04). KRAS wild‑type tumors were localized in the right colon (p=0.005) and tumors with the p.G13D point mutation (p=0.018) were diagnosed at non‑metastatic stages. In conclusion, KRAS point mutations in colorectal cancer exhibited a heterogeneous distribution in terms of tumor localization. In addition, the p.G13D point mutation was found to differ from other mutations in several aspects.Keywords
This publication has 22 references indexed in Scilit:
- Prognostic and Predictive Roles of KRAS Mutation in Colorectal CancerInternational Journal of Molecular Sciences, 2012
- Assessment of colorectal cancer molecular features along bowel subsites challenges the conception of distinct dichotomy of proximal versus distal colorectumGut, 2012
- Association of KRAS p.G13D Mutation With Outcome in Patients With Chemotherapy-Refractory Metastatic Colorectal Cancer Treated With CetuximabJAMA, 2010
- K-rasMutations and Benefit from Cetuximab in Advanced Colorectal CancerNew England Journal of Medicine, 2008
- Dietary folate intake and k‐ras mutations in sporadic colon and rectal cancer in the Netherlands Cohort StudyInternational Journal of Cancer, 2005
- The COSMIC (Catalogue of Somatic Mutations in Cancer) database and websiteBritish Journal of Cancer, 2004
- DNA Ploidy and S-phase fraction, but not p53 or NM23-H1 expression, predict outcome in colorectal cancer patients. Result of a 5-year prospective studyJournal of Cancer Research and Clinical Oncology, 2002
- Kirsten ras mutations in patients with colorectal cancer: the ‘RASCAL II’ studyBritish Journal of Cancer, 2001
- Genetic Alterations during Colorectal-Tumor DevelopmentNew England Journal of Medicine, 1988
- Most human carcinomas of the exocrine pancreas contain mutant c-K-ras genesCell, 1988